SCHEMBL16276963

SCHEMBL16276963

CCNC1(CC(=O)OCC)CCOCC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 2/20 0.40
▸ LMNA P02545 2/20 0.40
▸ POLB P06746 2/20 0.40
▸ GAA P10253 2/20 0.39
▸ MGAM O43451 1/20 0.39
▸ SI P14410 1/20 0.39
▸ MGAM2 Q2M2H8 1/20 0.39
▸ ALDH1A1 P00352 3/20 0.39
▸ L3MBTL1 Q9Y468 2/20 0.37
▸ RAB9A P51151 2/20 0.37
▸ RECQL P46063 1/20 0.35
▸ KMT2A Q03164 3/20 0.35
▸ NPSR1 Q6W5P4 2/20 0.34
▸ TRPA1 O75762 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ LIPE Q05469 1/20 0.33
▸ CNR2 P34972 1/20 0.32
▸ CYP2C9 P11712 1/20 0.32
▸ CYP2C19 P33261 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL16268608 0.98 TSHR (0.39) TSHRLMNAPOLBGAAMGAM
SCHEMBL16268571 0.81 GAA (0.41) TSHRLMNAPOLBGAAMGAM
SCHEMBL16276955 0.80 GAA (0.40) TSHRLMNAPOLBGAAMGAM
SCHEMBL24906928 0.78 ALDH1A1 (0.47) TSHRLMNAPOLBGAAMGAM
SCHEMBL8146725 0.78 TSHR (0.45) TSHRLMNAPOLBGAAMGAM
SCHEMBL2085077 0.76 TSHR (0.44) TSHRLMNAPOLBGAAMGAM
SCHEMBL16268204 0.76 TSHR (0.44) TSHRLMNAPOLBGAAMGAM
Hydrochloric Acid SCHEMBL16268518 0.75 TSHR (0.42) TSHRLMNAPOLBGAAMGAM
SCHEMBL17628821 0.73 GAA (0.42) TSHRLMNAPOLBGAAMGAM
SCHEMBL20855707 0.72 TSHR (0.41) TSHRLMNAPOLBGAAMGAM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9827249-B2 Use of condensed benzo[B]thiazine derivatives as cytoprotectants ARANDA PHARMA LTD (FI) 2017-11-28 — — US disclosed
US-9827249-B2 Use of condensed benzo[B]thiazine derivatives as cytoprotectants ARANDA PHARMA LTD (FI) 2017-11-28 — — US disclosed
US-20160106754-A1 USE OF CONDENSED BENZO[B]THIAZINE DERIVATIVES AS CYTOPROTECTANTS ARANDA PHARMA LTD (FI) 2016-04-21 — — US disclosed
US-20160106754-A1 USE OF CONDENSED BENZO[B]THIAZINE DERIVATIVES AS CYTOPROTECTANTS ARANDA PHARMA LTD (FI) 2016-04-21 — — US disclosed
WO-2014191632-A1 USE OF CONDENSED BENZO[B]THIAZINE DERIVATIVES AS CYTOPROTECTANTS MEDEIA THERAPEUTICS LTD (FI) 2014-12-04 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160106754-A1 USE OF CONDENSED BENZO[B]THIAZINE DERIVATIVES AS CYTOPROTECTANTS TXN2, GPX4, NQO1 TSHR 2096/4885LMNA 517/4885POLB 961/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback